• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Cost-effectiveness of percutaneous closure of a patent foramen ovale compared with medical management in patients with a cryptogenic stroke: from the US payer perspective.
CONCLUSION: Percutaneous PFO closure plus medical management represents a cost-effective approach for lowering the risk of recurrent stroke compared with medical management alone. PMID: 31025589 [PubMed - as supplied by publisher]
Source: Journal of Medical Economics - April 28, 2019 Category: Health Management Tags: J Med Econ Source Type: research

Evaluating the cost-effectiveness of percutaneous closure of a patent foramen ovale versus medical management in patients with a cryptogenic stroke: from the UK payer perspective.
CONCLUSION: Percutaneous closure of a PFO is cost-effective compared with antiplatelet therapy alone, underlining the economic benefits potentially afforded by this treatment in selected patients. PMID: 30424680 [PubMed - as supplied by publisher]
Source: Journal of Medical Economics - November 16, 2018 Category: Health Management Tags: J Med Econ Source Type: research

Cost-effectiveness of percutaneous patent foramen ovale closure as secondary stroke prevention.
CONCLUSIONS: Considering the UK healthcare system perspective, percutaneous PFO closure in cryptogenic ischemic stroke patients is a cost-effective stroke prevention strategy compared to medical therapy alone. Its cost-effectiveness was driven by substantial reduction in recurrent strokes and patients' improved health-related quality-of-life. PMID: 29564942 [PubMed - as supplied by publisher]
Source: Journal of Medical Economics - March 23, 2018 Category: Health Management Tags: J Med Econ Source Type: research